150 related articles for article (PubMed ID: 36873273)
1. Effect of metformin alone and in combination with etoposide and epirubicin on proliferation, apoptosis, necrosis, and migration of B-CPAP and SW cells as thyroid cancer cell lines.
Ghavami G; Kiasari RE; Pakzad F; Sardari S
Res Pharm Sci; 2023 Apr; 18(2):185-201. PubMed ID: 36873273
[TBL] [Abstract][Full Text] [Related]
2. Tyrosine kinase receptor inhibitor-targeted combined chemotherapy for metastatic bladder cancer.
Wu CL; Ping SY; Yu CP; Yu DS
Kaohsiung J Med Sci; 2012 Apr; 28(4):194-203. PubMed ID: 22453067
[TBL] [Abstract][Full Text] [Related]
3. Effects of prolonged exposure to low dose metformin in thyroid cancer cell lines.
Kheder S; Sisley K; Hadad S; Balasubramanian SP
J Cancer; 2017; 8(6):1053-1061. PubMed ID: 28529619
[No Abstract] [Full Text] [Related]
4. Metformin synergistically enhances antiproliferative effects of cisplatin and etoposide in NCI-H460 human lung cancer cells.
Teixeira SF; Guimarães Idos S; Madeira KP; Daltoé RD; Silva IV; Rangel LB
J Bras Pneumol; 2013; 39(6):644-9. PubMed ID: 24473757
[TBL] [Abstract][Full Text] [Related]
5. [Troglitazone sensitizes effect of epirubicin on breast cancer cells].
Sun JX; Meng ZX; Lv JH; Sun YJ
Ai Zheng; 2006 Aug; 25(8):960-6. PubMed ID: 16965675
[TBL] [Abstract][Full Text] [Related]
6. Vitamin D3 enhances antitumor activity of metformin in human bladder carcinoma SW-780 cells.
Guo LS; Li HX; Li CY; Zhang SY; Chen J; Wang QL; Gao JM; Liang JQ; Gao MT; Wu YJ
Pharmazie; 2015 Feb; 70(2):123-8. PubMed ID: 25997253
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of DNA-PK potentiates the synergistic effect of NK314 and etoposide combination on human glioblastoma cells.
Kopa P; Macieja A; Gulbas I; Pastwa E; Poplawski T
Mol Biol Rep; 2020 Jan; 47(1):67-76. PubMed ID: 31583565
[TBL] [Abstract][Full Text] [Related]
8. The Apoptosis Mechanism of Epirubicin Combined with BCG on Human Bladder Cancer Cells.
Luo Y; Fu X; Han B; Zhang F; Yuan L; Men H; Zhang S; Tian S; Dong B; Meng M
Anticancer Agents Med Chem; 2020; 20(13):1571-1581. PubMed ID: 32357825
[TBL] [Abstract][Full Text] [Related]
9. Synergistic anti-proliferative effect of metformin and sorafenib on growth of anaplastic thyroid cancer cells and their stem cells.
Chen G; Nicula D; Renko K; Derwahl M
Oncol Rep; 2015 Apr; 33(4):1994-2000. PubMed ID: 25683253
[TBL] [Abstract][Full Text] [Related]
10. Metformin synergistically enhances antitumor activity of histone deacetylase inhibitor trichostatin a against osteosarcoma cell line.
Duo J; Ma Y; Wang G; Han X; Zhang C
DNA Cell Biol; 2013 Apr; 32(4):156-64. PubMed ID: 23451817
[TBL] [Abstract][Full Text] [Related]
11. Metformin exerts an antitumor effect by inhibiting bladder cancer cell migration and growth, and promoting apoptosis through the PI3K/AKT/mTOR pathway.
Shen Z; Xue D; Wang K; Zhang F; Shi J; Jia B; Yang D; Zhang Q; Zhang S; Jiang H; Luo D; Li X; Zhong Q; Zhang J; Peng Z; Han Y; Sima C; He X; Hao L
BMC Urol; 2022 May; 22(1):79. PubMed ID: 35610639
[TBL] [Abstract][Full Text] [Related]
12. Metformin and the mTOR inhibitor everolimus (RAD001) sensitize breast cancer cells to the cytotoxic effect of chemotherapeutic drugs in vitro.
Liu H; Scholz C; Zang C; Schefe JH; Habbel P; Regierer AC; Schulz CO; Possinger K; Eucker J
Anticancer Res; 2012 May; 32(5):1627-37. PubMed ID: 22593441
[TBL] [Abstract][Full Text] [Related]
13. Schedule-dependent effects of kappa-selenocarrageenan in combination with epirubicin on hepatocellular carcinoma.
Ji YB; Ling N; Zhou XJ; Mao YX; Li WL; Chen N
Asian Pac J Cancer Prev; 2014; 15(8):3651-7. PubMed ID: 24870773
[TBL] [Abstract][Full Text] [Related]
14. Synergistic effects of metformin and curcumin on cytotoxicity of chemotherapy drugs using a gastric cancer cell line model.
Zarei E; Sefidi-Heris Y; Saadat I
EXCLI J; 2021; 20():1488-1498. PubMed ID: 34924899
[TBL] [Abstract][Full Text] [Related]
15. [Dose-response effect of drugs in the chemotherapy of small-cell bronchial carcinoma].
Kostić D; Jelić S; Radulović S
Srp Arh Celok Lek; 2000; 128(3-4):75-9. PubMed ID: 10932613
[TBL] [Abstract][Full Text] [Related]
16. Effects of Epirubicin and Cisplatin Against 4T1 Breast Cancer Cells are Enhanced by Myrtucommulone-A.
Izgi K; Iskender B; Sakalar C; Arslanhan A; Yuksek EH; Hizar E; Canatan H
Anticancer Agents Med Chem; 2017; 17(3):404-414. PubMed ID: 27039926
[TBL] [Abstract][Full Text] [Related]
17. Prospective randomized phase III trial of etoposide/cisplatin versus high-dose epirubicin/cisplatin in small-cell lung cancer.
Artal-Cortés A; Gomez-Codina J; Gonzalez-Larriba JL; Barneto I; Carrato A; Isla D; Camps C; Garcia-Giron C; Font A; Meana A; Lomas M; Vadell C; Arrivi A; Alonso C; Maestu I; Campbell J; Rosell R
Clin Lung Cancer; 2004 Nov; 6(3):175-83. PubMed ID: 15555219
[TBL] [Abstract][Full Text] [Related]
18. Synergistic effect of metformin and vemurufenib (PLX4032) as a molecular targeted therapy in anaplastic thyroid cancer: an in vitro study.
Durai L; Ravindran S; Arvind K; Karunagaran D; Vijayalakshmi R
Mol Biol Rep; 2021 Nov; 48(11):7443-7456. PubMed ID: 34716862
[TBL] [Abstract][Full Text] [Related]
19. Standard- and high-dose etoposide, ifosfamide, carboplatin, and epirubicin in 100 patients with small-cell lung cancer: a mature follow-up report.
Fetscher S; Brugger W; Engelhardt R; Kanz L; Hasse J; Frommhold H; Lange W; Mertelsmann R
Ann Oncol; 1999 May; 10(5):561-7. PubMed ID: 10416006
[TBL] [Abstract][Full Text] [Related]
20. Synergistic Combination of Histone Deacetylase Inhibitor Suberoylanilide Hydroxamic Acid and Natural Flavonoid Curcumin Exhibits Anticancer and Antibacterial Activity.
Altundağ EM; Toprak K; Şanlıtürk G; Güran M; Özbilenler C; Kerküklü NR; Yılmaz AM; Yalçın AS
Anticancer Agents Med Chem; 2021; 21(10):1301-1308. PubMed ID: 33023457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
